BMY Financial Facts
Earnings Before Income Taxes: 1.56BResearch and development: 1.14B
See Full Income Statement
Other assets: 918M
Goodwill: 6.88B
See Full Balance Sheet
Bristol-Myers Squibb Company (BMY) Earnings
|
Expand Research on BMY
| Next EPS Date | 7/25/24 *Est. | EPS Growth Rate | -314.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | +5.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -5.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/4/22 |  |
Q421 | $1.83 | $1.82 | +$0.01 | $12B | $12.12B | = |  | | Details |
| 7/27/23 | Q223 | $1.75 | $1.98 | -$0.23 | $11.2B | $11.81B | = | | | Details | |
| 10/27/21 | |
Q321 | $2.00 | $1.94 | +$0.06 | $11.62B | $11.64B | = | | | Details |
| 4/27/23 | Q123 | $2.05 | $1.97 | +$0.08 | $11.3B | $11.49B | = | | | Details | |
| 4/25/24 | Q124 | -$4.40 | -$4.47 | +$0.07 | $11.9B | $11.46B | = | | | Details | |
| 7/27/22 | |
Q222 | $1.93 | $1.80 | +$0.13 | $11.89B | $11.44B | = | | | Details |
| 4/29/22 | |
Q122 | $1.96 | $1.94 | +$0.02 | $11.65B | $11.42B | = | | | Details |
| 7/28/21 | |
Q221 | $1.93 | $1.91 | +$0.02 | $11.7B | $11.33B | = | | | Details |
